Ministry of Health and Family Welfare proposes to exempt Gelatine capsules from labelling requirement under the Drugs and Cosmetics Rules, 1945 by Lexplosion | Aug 21, 2018 | EHS, Healthcare, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) has published the Draft Drugs and Cosmetics... Read More
NPPA extends the period of ceiling prices of Orthopaedic knee implants till 15th August, 2019 by Lexplosion | Aug 17, 2018 | EHS, Pharmaceuticals, statesIn a recent notification dated 16th August, 2018, the National Pharmaceutical Pricing Authority... Read More
Ministry of Health and Family Welfare invites comments on its plan to re-classify ‘Oxytocin as a Schedule H1 category Drug’ till 17th August, 2018 by Lexplosion | Aug 13, 2018 | EHS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) proposes to omit oxytocin from the category... Read More
CDSCO will stop accepting physical application for Registration and Re-registration of ethics committee from 1st September, 2018 by Lexplosion | Aug 13, 2018 | EHS, Pharmaceuticals, statesThe Central Drugs Standard Control Organization (“CDSCO”) has notified that physical application... Read More
Cabinet gives a nod to DNA Technology (Use and Application) Regulation Bill, 2018 by Lexplosion | Jul 12, 2018 | Healthcare, OPS, Pharmaceuticals, statesThe DNA Technology (Use and Application) Regulation Bill 2018 (“Bill”) has been approved by the... Read More
Ministry of Health and Family Welfare imposes ban on manufacturing of Oxytocin by private manufacturers effective 1.07.2018 by Lexplosion | Jul 11, 2018 | OPS, Pharmaceuticals, statesIn a Press Release dated 27th June, 2018, the Ministry of Health and Family Welfare has made the... Read More
